BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$2.69B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.49B |
| 3 |
Corteva
CTVA
|
+$1.57B |
| 4 |
Alibaba
BABA
|
+$1.18B |
| 5 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$2.29B |
| 2 |
Apple
AAPL
|
+$1.42B |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$1.06B |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$957M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$888M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.94% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 13.61% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Industrials | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
iShares MSCI Mexico ETF
EWW
$1.92B
| $1.24M | ﹤0.01% |
28,481
-2,082
| -7% | -$93.4K |
|
3877
Stellus Capital Investment Corp
SCM
$217M
| $1.23M | ﹤0.01% |
89,105
+18,534
| +26% | +$262K |
|
3878
AB InBev
BUD
$167B
| $1.23M | ﹤0.01% |
13,885
+13,150
| +1,789% | +$1.13M |
|
|
QUMU
3879
DELISTED
Qumu Corp.
QUMU
| $1.22M | ﹤0.01% |
294,765
+23,021
| +8% | +$77.6K |
|
|
ZSAN
3880
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.2M | ﹤0.01% |
10,482
+1,574
| +18% | +$186K |
|
3881
Cartesian Therapeutics
RNAC
$229M
| $1.2M | ﹤0.01% |
22,261
-34,138
| -61% | -$2.33M |
|
|
AGTC
3882
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $1.18M | ﹤0.01% |
310,941
+28,429
| +10% | +$117K |
|
|
BWG
3883
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$130M
| $1.17M | ﹤0.01% |
99,213
| – | – |
|
3884
Bausch Health
BHC
$2.57B
| $1.16M | ﹤0.01% |
46,086
-336,877
| -88% | -$8M |
|
|
CEMI
3885
DELISTED
Chembio diagnostics, Inc.
CEMI
| $1.16M | ﹤0.01% |
190,838
+141,742
| +289% | +$956K |
|
3886
electroCore
ECOR
$54.8M
| $1.15M | ﹤0.01% |
38,388
+1,370
| +4% | +$83.4K |
|
|
FCRD
3887
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $1.12M | ﹤0.01% |
168,920
+28,990
| +21% | +$194K |
|
|
ACH
3888
DELISTED
Alum Corp of China Ltd
ACH
| $1.12M | ﹤0.01% |
127,473
+828
| +0.7% | +$7.8K |
|
3889
SCYNEXIS
SCYX
$48.1M
| $1.12M | ﹤0.01% |
10,686
+6,446
| +152% | +$744K |
|
3890
Gladstone Capital
GLAD
$422M
| $1.12M | ﹤0.01% |
59,675
-3,411
| -5% | -$63.6K |
|
3891
Star Group
SGU
$412M
| $1.12M | ﹤0.01% |
+111,972
| New | +$1.09M |
|
|
MLNT
3892
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $1.11M | ﹤0.01% |
167,564
-313,617
| -65% | -$1.19M |
|
|
VIVS
3893
VivoSim Labs
VIVS
$1.2M
| $1.09M | ﹤0.01% |
8,712
-21,267
| -71% | -$4.02M |
|
|
INAP
3894
DELISTED
Internap Corporation
INAP
| $1.09M | ﹤0.01% |
361,113
-1,096,026
| -75% | -$3.9M |
|
3895
Biglari Holdings Class A
BH.A
$1.25B
| $1.08M | ﹤0.01% |
2,037
-4,706
| -70% | -$3M |
|
3896
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $1.08M | ﹤0.01% |
21,202
-51
| -0.2% | -$2.57K |
|
3897
Champions Oncology
CSBR
$74.5M
| $1.07M | ﹤0.01% |
137,027
+14,733
| +12% | +$129K |
|
3898
Kodak
KODK
$822M
| $1.07M | ﹤0.01% |
446,590
-736,443
| -62% | -$1.83M |
|
|
DNI
3899
DELISTED
Dividend and Income Fund
DNI
| $1.06M | ﹤0.01% |
92,100
| – | – |
|
|
SHLO
3900
DELISTED
Shiloh Industries Inc
SHLO
| $1.06M | ﹤0.01% |
218,071
-703,430
| -76% | -$3.7M |
|
Similar funds
BlackRock's Q2 2019 Portfolio in Review
As of Q2 2019, BlackRock held 5,206 positions worth $2.34T, up 4.4% from $2.24T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q2 2019 filing shows 233 new, 2,845 increased, 1,535 reduced and 146 closed positions. Its largest new stake was Dow Inc: 50,959,336 shares worth $2.51B. The largest sale was DuPont de Nemours, an estimated $2.29B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q2 2019 buy was Dow Inc: 50,959,336 shares worth $2.51B.
- BlackRock added most to iShares MSCI EAFE ETF in Q2 2019, an estimated $2.49B increase.
- BlackRock's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $2.29B.
- BlackRock fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $957M.
- BlackRock's ten largest holdings make up 15% of its $2.34T portfolio in Q2 2019.
- BlackRock opened 233 new positions and closed 146 in Q2 2019.
- BlackRock's portfolio value rose 4.4% quarter-over-quarter to $2.34T.
Based on BlackRock's 13F filing for Q2 2019, filed 13 Aug 2019.